| | | | View:
Latest News | Top Stories | | | 1.
|
Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
-
PR Newswire
-
2 hours, 23 minutes ago
Nektar Therapeutics today announced the promotion of Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer.
| | | 2.
|
Emisphere Technologies Announces Extension of Maturity Date for Novartis Convertible Promissory Note
-
Business Wire
-
Mon 8:45 am ET
CEDAR KNOLLS, N.J.----Emisphere Technologies, Inc. , a biopharmaceutical company that focuses on a unique and improved delivery of pharmaceutical compounds and nutritional supplements using its Eligen® Technology, today announced that Novartis Pharma AG has agreed to extend the maturity date of Emisphere’s Convertible Promissory Note to February 26, 2010.
| | | 3.
|
Emisphere Technologies to Present at the New York Society of Security Analysts' 13th Annual Biotech & Specialty Pharma Investment Conference
-
Business Wire
-
Tue Nov 24
CEDAR KNOLLS, N.J.----Emisphere Technologies, Inc. , a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules and pharmaceutical compounds using its Eligen® Technology, today announced that President and Chief Executive Officer, Michael V.
| | | 4.
|
Delcath Systems, Inc. Sponsors Satellite Session at World Meeting of Melanoma/Skin Cancer Centers
-
PR Newswire
-
Tue Nov 24
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, recently sponsored a Satellite Symposium at the World Meeting of Melanoma/Skin Cancer Centers in Berlin, Germany.
| | | 5.
|
Generex Scientist Makes Presentation at National Influenza Congress
-
GlobeNewswire
-
Mon Nov 23
WORCESTER, Mass. -- Generex Biotechnology Corporation announced today that Dr. Douglas Powell, Director of Immunobiology at Antigen Express, Inc. , Generex's wholly-owned immunotherapeutics subsidiary, made a presentation on the Company's H1N1 Swine Flu program at a national symposium on influenza.
| | | 6.
|
Delcath Systems share offering raises $32 million
-
AP
-
Wed Nov 18
Delcath Systems Inc., a developer of a cancer-drug delivery device, said Wednesday it raised $32.4 million in net proceeds from a public stock offering.
| | | 7.
|
NovaDel Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2009
-
Business Wire
-
Mon Nov 16
FLEMINGTON, N.J.----NovaDel Pharma Inc. , a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, reported financial results for its third quarter and nine months ended September 30, 2009.
| | | 8.
|
Alkermes' Vivitrol succeeds in opiate study
-
AP
-
Mon Nov 16
Alkermes Inc. said a late stage clinical trial shows its drug Vivitrol, which is used to help alcoholics quit drinking, also helped opioid addicts stay off drugs.
| | | 9.
|
NovaDel Signs Exclusive License and Distribution Agreement with Hi-Tech Pharmacal Co., Inc.'s Subsidiary to Commercialize and Manufacture ZolpiMist in the US and Canada
-
Business Wire
-
Mon Nov 16
FLEMINGTON, N.J.----NovaDel Pharma Inc. today announced its entry into an exclusive license and distribution agreement with ECR Pharmaceuticals Company, Inc., a wholly owned subsidiary of Hi-Tech Pharmacal Co., Inc. to commercialize and manufacture ZolpiMistâ„¢ in the United States and Canada.
| | | 10.
|
Matrixx Initiatives, Inc. Reports Fiscal 2010 Second Quarter Sales and Net Income
-
PR Newswire
-
Mon Oct 26
Matrixx Initiatives, Inc. , an over-the-counter healthcare company that develops and markets Zicam® products, today announced financial results for its fiscal second quarter and six months ended September 30, 2009.
| |
| |
|
